RepliCel contracts Accerise to plan phase 2 cell therapy trials in Japan
Biospace - 19-May-2021Successful trial results could bring us skin rejuvenation & tendon regeneration products
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
Fastest growing CRO based in Tokyo
Accerise is a leading contract research organization (CRO), developing human resources and drug development business. It was established in September 2004. It is also focused on CRA dispatching, MR dispatching (CSO), professional recruitment of employees.
Visit website: https://accerise.co.jp/english/
Details last updated 22-May-2021
Successful trial results could bring us skin rejuvenation & tendon regeneration products